In Season 2 of Raising Biotech, a clear theme emerged: AI is revolutionizing biotech in ways that would have seemed like pure science fiction just a decade ago. Through conversations with pioneering founders, scientists, and industry experts, we delved into how these companies are leveraging AI to push the boundaries of medicine—from ultra-targeted gene delivery to discovering therapeutic possibilities in unexpected places.
Take Mana.bio and Cerevance, for example. Using AI to target therapies with extreme precision, Mana.bio’s lipid nanoparticles now allow gene therapies to reach organs we once thought were off-limits. Meanwhile, Cerevance’s NetSeq platform analyzes human brain tissue samples to uncover neuron-specific targets for treating diseases like Parkinson’s. It’s a level of precision that would have been unimaginable without AI driving these complex discoveries.
In another unique twist, Fauna Bio is using AI to examine the genetic traits of resilient species like hibernating squirrels, aiming to translate these survival strategies into therapies for human diseases. This cross-species approach offers a fascinating new avenue, one that’s only achievable because of the powerful AI tools available today.
And in the oncology space, iOmx is taking immunotherapy to the next level by using AI to screen the entire genome for immune escape pathways in tumors—moving beyond standard cancer targets and opening doors to entirely new treatments. Ray Therapeutics, too, is innovating with AI, optimizing light-sensitive proteins for vision restoration that work under normal lighting conditions.
It’s been inspiring to see how each company is using AI not just to accelerate research but to achieve breakthroughs that simply weren’t possible before. These stories show how AI is doing more than speeding up drug discovery—it’s enabling entirely new ways to think about, design, and deliver therapies.
Want to go deeper and hear exactly how AI is transforming biotech from those on the frontlines? Tune in to Season 2 of Raising Biotech for a closer look at the innovations shaping the future of medicine.